Your browser doesn't support javascript.
loading
Population-based microcephaly surveillance in the United States, 2009 to 2013: An analysis of potential sources of variation.
Cragan, Janet D; Isenburg, Jennifer L; Parker, Samantha E; Alverson, C J; Meyer, Robert E; Stallings, Erin B; Kirby, Russell S; Lupo, Philip J; Liu, Jennifer S; Seagroves, Amanda; Ethen, Mary K; Cho, Sook Ja; Evans, MaryAnn; Liberman, Rebecca F; Fornoff, Jane; Browne, Marilyn L; Rutkowski, Rachel E; Nance, Amy E; Anderka, Marlene; Fox, Deborah J; Steele, Amy; Copeland, Glenn; Romitti, Paul A; Mai, Cara T.
Afiliação
  • Cragan JD; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Isenburg JL; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Parker SE; Carter Consulting Inc., Atlanta, Georgia.
  • Alverson CJ; Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts.
  • Meyer RE; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Stallings EB; State Center for Health Statistics, N.C. Division of Public Health, Raleigh, North Carolina.
  • Kirby RS; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Lupo PJ; Carter Consulting Inc., Atlanta, Georgia.
  • Liu JS; Department of Community and Family Health, College of Public Health, University of South Florida, Tampa, Florida.
  • Seagroves A; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Ethen MK; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Cho SJ; Leidos Holdings, Inc., Reston, Virginia.
  • Evans M; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Liberman RF; Carter Consulting Inc., Atlanta, Georgia.
  • Fornoff J; Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, Texas.
  • Browne ML; Division of Community and Family Health, Minnesota Department of Health, St. Paul, Minnesota.
  • Rutkowski RE; Oregon Birth Anomalies Surveillance System, Oregon Public Health Division, Portland, Oregon.
  • Nance AE; Center for Birth Defects Research and Prevention, Massachusetts Department of Public Health, Boston, Massachusetts.
  • Anderka M; Division of Epidemiologic Studies, Illinois Department of Public Health, Springfield, Illinois.
  • Fox DJ; New York State Department of Health, Albany, New York.
  • Steele A; Department of Community and Family Health, College of Public Health, University of South Florida, Tampa, Florida.
  • Copeland G; Utah Birth Defect Network, Division of Family Health and Preparedness, Utah Department of Health, Salt Lake City, Utah.
  • Romitti PA; National Birth Defects Prevention Network, Houston, Texas.
  • Mai CT; New York State Department of Health, Albany, New York.
Birth Defects Res A Clin Mol Teratol ; 106(11): 972-982, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27891783
ABSTRACT

BACKGROUND:

Congenital microcephaly has been linked to maternal Zika virus infection. However, ascertaining infants diagnosed with microcephaly can be challenging.

METHODS:

Thirty birth defects surveillance programs provided data on infants diagnosed with microcephaly born 2009 to 2013. The pooled prevalence of microcephaly per 10,000 live births was estimated overall and by maternal/infant characteristics. Variation in prevalence was examined across case finding methods. Nine programs provided data on head circumference and conditions potentially contributing to microcephaly.

RESULTS:

The pooled prevalence of microcephaly was 8.7 per 10,000 live births. Median prevalence (per 10,000 live births) was similar among programs using active (6.7) and passive (6.6) methods; the interdecile range of prevalence estimates was wider among programs using passive methods for all race/ethnicity categories except Hispanic. Prevalence (per 10,000 live births) was lowest among non-Hispanic Whites (6.5) and highest among non-Hispanic Blacks and Hispanics (11.2 and 11.9, respectively); estimates followed a U-shaped distribution by maternal age with the highest prevalence among mothers <20 years (11.5) and ≥40 years (13.2). For gestational age and birth weight, the highest prevalence was among infants <32 weeks gestation and infants <1500 gm. Case definitions varied; 41.8% of cases had an HC ≥ the 10th percentile for sex and gestational age.

CONCLUSION:

Differences in methods, population distribution of maternal/infant characteristics, and case definitions for microcephaly can contribute to the wide range of observed prevalence estimates across individual birth defects surveillance programs. Addressing these factors in the setting of Zika virus infection can improve the quality of prevalence estimates. Birth Defects Research (Part A) 106972-982, 2016. © 2016 Wiley Periodicals, Inc.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monitoramento Epidemiológico / Zika virus / Infecção por Zika virus / Microcefalia Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monitoramento Epidemiológico / Zika virus / Infecção por Zika virus / Microcefalia Idioma: En Ano de publicação: 2016 Tipo de documento: Article